Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: AGC Biologics, Aicuris Anti-infective Cures, Ajinomoto Bio-Pharma Services, Anixa, Arctic Vision, Beyondspring, Bioaegis, Biological E., Bold, Bridgebio, Caribou Biosciences, Carsgen, Cerecor, Certara, Dr. Falk, Dynavax, Eyenovia, Genscript, Heat Biologics, Hifibio, Innate, Isofol Medical, Janone, JN Nova, Kiadis, Lianbio, Memo, Merck, Molecular Partners, Monopar, Novavax, Novome, Ono, Ontochem, Ose Immunotherapeutics, Pluristem, Prometheus, Qbiotics, Revive, Saillant, SK Group, Solasia, Tevogen, Xbiotech.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Atriva, Genome and Co., Scioto, Organicell Regenerative Medicine.

Quarterly snapshots from biopharma companies with marketed products, including: Zai Lab.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Zai Lab.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Clearmask, Diazyme, Genosity, Illuminoss, Sensiva.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Apotheka Systems, Aspen Imaging Healthcare, Aspero, Bigfinite, Biolase, Cerner, Cheona Health, CHF Solutions, Deer Horn Capital, Facedrive, Forward Industries, Huami, Impact@Resolve, Imt Analytics, Ivenix, Kablooe Design, MDlink, Montefiore, NIH, NYU Langone, Orpheus Medica, Resolve, Sanara Medtech, Skywater, Telix Pharmaceuticals, Tenacore, Therma Bright, Tokimus Biotech, Zyter.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cala Health, Edap, Gt Medical Technologies.

Med-tech firms raising money in public or private financings, including: Bridge Connector, Rimsys.

New hires and promotions in the med-tech industry, including: Alveo Technologies, BD, Cala Health, Hydrophilix, Painteq, Sqi Diagnostics.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Emmaus, Immatics, Kimera, Krystal.